BNP Paribas Financial Markets’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-169,082
Closed -$3.99M 4288
2023
Q4
$3.99M Buy
169,082
+104,776
+163% +$1.87M 0.01% 1555
2023
Q3
$959K Buy
64,306
+38,727
+151% +$513K ﹤0.01% 2356
2023
Q2
$280K Sell
25,579
-147,135
-85% -$1.37M ﹤0.01% 2892
2023
Q1
$1.51M Buy
172,714
+172,193
+33,050% +$1.38M ﹤0.01% 2027
2022
Q4
$3.27K Buy
521
+520
+52,000% +$1.98K ﹤0.01% 3698
2022
Q3
$4 Sell
1
-9,986
-100% -$35.9K ﹤0.01% 4716
2022
Q2
$29.5K Sell
9,987
-9
-0.1% -$21 ﹤0.01% 3657
2022
Q1
$31.1K Sell
9,996
-114,803
-92% -$361K ﹤0.01% 3656
2021
Q4
$422K Buy
124,799
+110,915
+799% +$421K ﹤0.01% 3085
2021
Q3
$50.7K Buy
13,884
+6,938
+100% +$27.3K ﹤0.01% 3515
2021
Q2
$30.3K Sell
6,946
-21,879
-76% -$97K ﹤0.01% 3425
2021
Q1
$131K Buy
28,825
+15,948
+124% +$85.8K ﹤0.01% 3232
2020
Q4
$73.9K Sell
12,877
-7,989
-38% -$60.5K ﹤0.01% 3364
2020
Q3
$151K Buy
20,866
+13,340
+177% +$71.3K ﹤0.01% 2892
2020
Q2
$26.3K Sell
7,526
-17,486
-70% -$50.5K ﹤0.01% 3274
2020
Q1
$37K Buy
25,012
+17,079
+215% +$28.7K ﹤0.01% 3690
2019
Q4
$15.5K Sell
7,933
-2,000
-20% -$7.51K ﹤0.01% 4060
2019
Q3
$50.9K Buy
9,933
+3,246
+49% +$19.7K ﹤0.01% 3470
2019
Q2
$47.9K Sell
6,687
-5,747
-46% -$65.1K ﹤0.01% 3445
2019
Q1
$165K Buy
+12,434
New +$132K ﹤0.01% 2808
2018
Q4
Sell
-1,927
Closed -$21.4K 4459
2018
Q3
$21.4K Hold
1,927
﹤0.01% 3389
2018
Q2
$25.9K Buy
+1,927
New +$24.1K ﹤0.01% 3393
2015
Q4
Sell
-55,000
Closed -$107K 3650
2015
Q3
$107K Buy
55,000
+10,000
+22% +$27.2K ﹤0.01% 2352
2015
Q2
$121K Buy
45,000
+25,000
+125% +$103K ﹤0.01% 1981
2015
Q1
$138K Buy
+20,000
New +$192K ﹤0.01% 1655

Other funds holding CBAY